Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Annals of Human Genetics
|
August 5, 2009
The reduced folate carrier (SLC19A1) c.80G>A polymorphism is associated with red cell folate concentrations among women
Anna Stanisławska-Sachadyn, Laura E Mitchell, Jayne V Woodside, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 21, 2009
Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD
Zehong Wan, Dramane I Laine, Hongxing Yan, et al.
Annals of the American Thoracic Society
|
February 25, 2022
<i>Staphylococcus aureus</i> in Non-Cystic Fibrosis Bronchiectasis: Prevalence and Genomic Basis of High Inoculum β-Lactam Resistance
Alexandra K Mossman, Julianna Svishchuk, Barbara Jean M Waddell, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 27, 2012
Tyrosine urea muscarinic acetylcholine receptor antagonists: achiral quaternary ammonium groups
Qi Jin, Roderick S Davis, Ann M Bullion, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 22, 2002
A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit
Patricia L Podolin, Brian J Bolognese, James J Foley, et al.
Nature Methods
|
January 14, 2014
Transcriptome in vivo analysis (TIVA) of spatially defined single cells in live tissue
Ditte Lovatt, Brittani K Ruble, Jaehee Lee, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 26, 2013
Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases
Michael Salmon, Mark A Luttmann, James J Foley, et al.
The Journal of Clinical Investigation
|
October 27, 2009
Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers
Mark D Levin, Min Min Lu, Nataliya B Petrenko, et al.
Pharmacogenetics
|
October 12, 2004
A coding polymorphism in the CYSLT2 receptor with reduced affinity to LTD4 is associated with asthma
Sreekumar G Pillai, Diane J Cousens, Ashley A Barnes, et al.
British Journal of Pharmacology
|
April 27, 2005
Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375
Stephen A Douglas, David J Behm, Nambi V Aiyar, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Annals of Human Genetics
|
August 5, 2009
The reduced folate carrier (SLC19A1) c.80G>A polymorphism is associated with red cell folate concentrations among women
Anna Stanisławska-Sachadyn, Laura E Mitchell, Jayne V Woodside, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 21, 2009
Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD
Zehong Wan, Dramane I Laine, Hongxing Yan, et al.
Annals of the American Thoracic Society
|
February 25, 2022
<i>Staphylococcus aureus</i> in Non-Cystic Fibrosis Bronchiectasis: Prevalence and Genomic Basis of High Inoculum β-Lactam Resistance
Alexandra K Mossman, Julianna Svishchuk, Barbara Jean M Waddell, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 27, 2012
Tyrosine urea muscarinic acetylcholine receptor antagonists: achiral quaternary ammonium groups
Qi Jin, Roderick S Davis, Ann M Bullion, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 22, 2002
A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit
Patricia L Podolin, Brian J Bolognese, James J Foley, et al.
Nature Methods
|
January 14, 2014
Transcriptome in vivo analysis (TIVA) of spatially defined single cells in live tissue
Ditte Lovatt, Brittani K Ruble, Jaehee Lee, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 26, 2013
Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases
Michael Salmon, Mark A Luttmann, James J Foley, et al.
The Journal of Clinical Investigation
|
October 27, 2009
Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers
Mark D Levin, Min Min Lu, Nataliya B Petrenko, et al.
Pharmacogenetics
|
October 12, 2004
A coding polymorphism in the CYSLT2 receptor with reduced affinity to LTD4 is associated with asthma
Sreekumar G Pillai, Diane J Cousens, Ashley A Barnes, et al.
British Journal of Pharmacology
|
April 27, 2005
Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375
Stephen A Douglas, David J Behm, Nambi V Aiyar, et al.
Page
of 4